The relationship between interleukin-6 and functional connectivity in methamphetamine users
- PMID: 29689344
- PMCID: PMC5971003
- DOI: 10.1016/j.neulet.2018.04.037
The relationship between interleukin-6 and functional connectivity in methamphetamine users
Abstract
Methamphetamine (MA) causes an increase in pro-inflammatory cytokines in animal models and in humans. Resulting activation of microglia and neuro-inflammation could, via effects on reward networks, mediate behavioral characteristics of addiction. We examined the relationship between interleukin-6 (IL-6) and corticolimbic and striatolimbic resting-state functional connectivity (RSFC). Thirty adults diagnosed with MA dependence and 20 control subjects underwent a resting-state functional magnetic resonance imaging (fMRI) scan and gave a blood sample for determination of plasma IL-6 levels. Seed-based RSFC analyses were performed to examine the interactive effect of group and IL-6 on ventral striatal and prefrontal connectivity. Within the MA group, IL-6 levels were positively related to striatolimbic RSFC but negatively related to corticostriatal RSFC. Our findings with IL-6 support the idea that inflammation may at least partly mediate the link among MA use disorder, RSFC, and behavior, possibly via effects on mesolimbic and mesocortical dopaminergic systems.
Keywords: Corticostriatal; IL-6; Inflammation; Mesocorticolimbic; Methamphetamine; Resting-state functional connectivity.
Published by Elsevier B.V.
Figures

Similar articles
-
Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users.Mol Psychiatry. 2016 Nov;21(11):1554-1560. doi: 10.1038/mp.2015.223. Epub 2016 Feb 2. Mol Psychiatry. 2016. PMID: 26830141 Free PMC article.
-
Risky decision making, prefrontal cortex, and mesocorticolimbic functional connectivity in methamphetamine dependence.JAMA Psychiatry. 2014 Jul 1;71(7):812-20. doi: 10.1001/jamapsychiatry.2014.399. JAMA Psychiatry. 2014. PMID: 24850532 Free PMC article.
-
A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder.Drug Alcohol Depend. 2018 Nov 1;192:186-192. doi: 10.1016/j.drugalcdep.2018.07.045. Epub 2018 Sep 21. Drug Alcohol Depend. 2018. PMID: 30266003 Free PMC article. Clinical Trial.
-
Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging.Brain Res. 2015 Dec 2;1628(Pt A):174-85. doi: 10.1016/j.brainres.2014.10.044. Epub 2014 Nov 4. Brain Res. 2015. PMID: 25451127 Free PMC article. Review.
-
Corticolimbic dysregulation and chronic methamphetamine abuse.Addiction. 2007 Apr;102 Suppl 1:5-15. doi: 10.1111/j.1360-0443.2006.01777.x. Addiction. 2007. PMID: 17493049 Review.
Cited by
-
Probabilistic Reversal Learning Deficits in Patients With Methamphetamine Use Disorder-A Longitudinal Pilot Study.Front Psychiatry. 2020 Dec 9;11:588768. doi: 10.3389/fpsyt.2020.588768. eCollection 2020. Front Psychiatry. 2020. PMID: 33362606 Free PMC article.
-
The influence of adverse childhood experiences and depression on addiction severity among methamphetamine users: exploring the role of perseveration.Front Psychiatry. 2024 May 14;15:1382646. doi: 10.3389/fpsyt.2024.1382646. eCollection 2024. Front Psychiatry. 2024. PMID: 38807693 Free PMC article.
-
Characterization of serum and brain cytokine levels following prolonged binge-like methamphetamine self-administration and cued methamphetamine seeking.J Neuroimmunol. 2025 Mar 15;400:578530. doi: 10.1016/j.jneuroim.2025.578530. Epub 2025 Jan 17. J Neuroimmunol. 2025. PMID: 39854936
-
Oxidative Stress and Inflammatory Biomarkers in People with Methamphetamine Use Disorder.Clin Psychopharmacol Neurosci. 2023 Aug 31;21(3):572-582. doi: 10.9758/cpn.22.1047. Clin Psychopharmacol Neurosci. 2023. PMID: 37424424 Free PMC article.
-
Intermittent theta burst stimulation to the left dorsolateral prefrontal cortex improves cognitive function in polydrug use disorder patients: a randomized controlled trial.Front Psychiatry. 2023 May 25;14:1156149. doi: 10.3389/fpsyt.2023.1156149. eCollection 2023. Front Psychiatry. 2023. PMID: 37304431 Free PMC article.
References
-
- Clark KH, Wiley CA, Bradberry CW. Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection. Neurotox Res. 2013;23(2):174–88. - PubMed
-
- Goncalves J, Martins T, Ferreira R, Milhazes N, Borges F, Ribeiro CF, et al. Methamphetamine-induced early increase of IL-6 and TNF-alpha mRNA expression in the mouse brain. Ann N Y Acad Sci. 2008;1139:103–11. - PubMed
-
- LaVoie MJ, Card JP, Hastings TG. Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity. Exp Neurol. 2004;187(1):47–57. - PubMed
-
- Wisor JP, Schmidt MA, Clegern WC. Cerebral microglia mediate sleep/wake and neuroinflammatory effects of methamphetamine. Brain Behav Immun. 2011;25(4):767–76. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical